SCHEMBL30262159

SCHEMBL30262159

CSCC[C@H](NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ IL23R Q5VWK5 2/20 0.56
▸ OPRM1 P35372 5/20 0.55
▸ OPRD1 P41143 5/20 0.55
▸ OPRK1 P41145 2/20 0.55
▸ TFPI P10646 1/20 0.54
▸ GLP1R P43220 1/20 0.53
▸ GCGR P47871 1/20 0.53
▸ GIPR P48546 1/20 0.53
▸ PTH1R Q03431 1/20 0.52
▸ KEAP1 Q14145 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31182935 0.90 TFPI (0.62) IL23RTFPIGLP1RGCGRGIPR
SCHEMBL29811053 0.89 IL23R (0.59) IL23ROPRM1OPRD1OPRK1TFPI
SCHEMBL30668120 0.88 OPRM1 (0.60) OPRM1OPRD1OPRK1TFPIGLP1R
SCHEMBL30567786 0.88 TFPI (0.58) TFPIGLP1RPTH1R
SCHEMBL29609357 0.88 TFPI (0.64) IL23RTFPIGLP1RGCGRGIPR
SCHEMBL30083769 0.88 TFPI (0.63) IL23ROPRM1OPRD1OPRK1TFPI
SCHEMBL30726528 0.87 BACE1 (0.56) TFPIGLP1RGCGRGIPR
SCHEMBL30903291 0.87 TFPI (0.63) IL23RTFPIGLP1RGCGRGIPR
SCHEMBL29365490 0.87 TFPI (0.62) OPRM1OPRD1OPRK1TFPIGLP1R
SCHEMBL31000935 0.87 TFPI (0.65) OPRM1OPRD1OPRK1TFPIGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback